Olfactory dysfunction in the scenario of COVID-19 pandemic in patients screened by the telemonitoring.
Einstein (Sao Paulo)
; 19: eAO6204, 2021.
Article
em En, Pt
| MEDLINE
| ID: mdl-34644743
ABSTRACT
OBJECTIVE:
To assess the clinical and epidemiological profile of patients with olfactory dysfunction in the scenario of COVID-19 pandemic.METHODS:
The study selected patients with loss of smell, previously screened by telemonitoring system of the Municipal Health Department of Goiânia (GO), Brazil, who agreed to answer a questionnaire about COVID-19 symptoms and findings of exams. The interviews were conducted by six otolaryngologists, who applied the specific questionnaire, over the phone.RESULTS:
A total of 13,910 patients underwent telemonitoring, and 627 (4.51%) had olfactory loss complaints. Out of them, 330 were included in the survey. We observed a higher prevalence of altered smell in women (67%), and in patients aged under 50 years (86%). In most cases the manifestations had a sudden onset (70%), and in the first 5 days of illness (80%). The most prevalent associated symptom was a change in taste (89%), and only 2.7% of interviewed patients required hospitalization.CONCLUSION:
Anosmia in COVID-19 is more prevalent in females and individuals aged under 50 years. It is a relevant initial symptom predictive of the disease, together with dysgeusia.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Transtornos do Olfato
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
Idioma:
En
/
Pt
Ano de publicação:
2021
Tipo de documento:
Article